Effective vaccines, without a needle: Since the start of the COVID pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin, a development that could revolutionize ...
Oct 29, 2021
0
184
South Africa has approved a clinical trial for a COVID vaccine pill, Israeli pharmaceutical company Oramed said on Friday.
Oct 29, 2021
0
28
There's been a significant breakthrough in the development of a vaccine to prevent hookworm infection—a parasite which causes serious disease in tens of millions of people globally.
Oct 26, 2021
0
5
A dosing error made during an AstraZeneca-University of Oxford COVID-19 vaccine trial has led to a new dosage finding in mice, reports a new Northwestern Medicine study.
Oct 25, 2021
0
131
Children under 18 and people from dozens of countries with a shortage of vaccines will be exempt from new rules that will require most travelers to the United States be vaccinated against COVID-19, the Biden administration ...
Oct 25, 2021
0
5
When new Emory University faculty member Natalie Dean posted a primer on Twitter last year to demystify vaccine efficacy, she earned herself a fanbase outside the scientific community. Biostatisticians like Dean are challenged ...
Oct 22, 2021
0
11
Griffith University researchers are a step closer in the fight against malaria with the development of a broad-spectrum vaccine that can be freeze-dried making it suitable for deployment into malaria-endemic countries.
Oct 21, 2021
0
86
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the Pfizer/BioNTech BNT162B2 ...
Oct 21, 2021
0
3
In a development that could mean Johnson & Johnson might encounter resistance over its application for authorization of a booster shot of its coronavirus vaccine, a new analysis filed by the U.S. Food and Drug Administration ...
Oct 13, 2021
0
2
Germany's CureVac said Tuesday it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising second-generation jab.
Oct 12, 2021
0
3
